Building on these results (and those of others; S1 File & S1 Table), we set out to consolidate a panel of metabolite biomarkers which could be used in conjunction with PlGF to deliver accurate preeclampsia prediction in nulliparous women. The gene discussed is PGF; the disease is preeclampsia.